CND Life Sciences, Inc. — Form D

CND Life Sciences, Inc. of SCOTTSDALE, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-16. The offering totals $6.3M, of which $4.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (16)

NameRoleLocation
Enrique CarrazanaRelated PersonCoral Gables, FL
Christopher GibbonsRelated PersonBrookline, MA
Peter HarrisRelated PersonBrookline, MA
Todd LevineRelated PersonParadise Valley, AZ
Richard J. MorelloRelated PersonAtlanta, GA
Jack SeaverRelated PersonNew York, NY
Richard J MorelloDirectorAtlanta, GA
Richard J MorelloExecutive OfficerAtlanta, GA
Todd J LevineDirectorParadise Valley, AZ
Todd J LevineExecutive OfficerParadise Valley, AZ
Jack J SeaverDirectorNew York, NY
Peter J HarrisDirectorBrookline, MA
Peter J HarrisExecutive OfficerBrookline, MA
Christopher J GibbonsDirectorBrookline, MA
Roy J FreemanDirectorBrookline, MA
Enrique J CarrazanaDirectorPleasanton, CA

Other filings by this issuer (11)

FiledFormOfferingSold
2026-08-03D/A$6.3M$6.3M
2025-05-06D/A$9.0M$8.6M
2025-04-15D/A$9.0M$3.7M
2025-03-06D$7.5M$3.5M
2024-03-27D$6.0M$2.0M
2023-07-24D$1.5M$1.5M
2023-03-24D/A$4.5M$4.5M
2022-09-22D$4.0M$2.5M
2021-11-10D$5.0M$4.2M
2021-04-28D/A$2.9M$2.9M
2021-01-20D$2.5M$825K

More